Mahopac, NY, United States of America

Amy-Lee Bredlau

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Approaches to Brain Cancer Treatment by Amy-Lee Bredlau**

Introduction

Amy-Lee Bredlau, an inventor based in Mahopac, NY, has made significant strides in medical innovation, particularly in the treatment of brain cancer. With one notable patent to his name, Bredlau’s work focuses on combining advanced biological methods to enhance therapeutic outcomes for patients battling this challenging condition.

Latest Patents

Bredlau holds a patent centered on a combination therapy for brain cancer. This innovative methodology involves the evaluation of biological samples for specific microRNAs (miRNAs) and the administration of interleukin-12 (IL-12), an immunogenic composition of human telomerase reverse transcriptase (hTERT), Wilms Tumor-1 (WT-1), and prostate specific membrane antigen (PSMA), as well as an anti-programmed cell death receptor 1 (PD-1) antibody. The treatment protocol is aimed at subjects exhibiting increased expression levels of particular miRNAs or their variants compared to control populations, offering a targeted approach to therapy. Additionally, the patent details methods for analyzing mRNA biomarkers in tumor samples to further refine treatment eligibility based on specific gene expression profiles.

Career Highlights

Bredlau's professional journey includes vital roles at prominent biopharmaceutical companies. He has worked with Inovio Pharmaceuticals and Regeneron Pharmaceuticals, where his expertise has contributed to groundbreaking research and development in cancer therapies. His patent represents a culmination of his experience and dedication to medical advancement.

Collaborations

Throughout his career, Bredlau has collaborated with esteemed colleagues in the field, including Israel Lowy and Jeffrey Skolnik. These partnerships highlight the collaborative nature of innovation in medical research, bringing together diverse expertise to combat complex diseases like brain cancer.

Conclusion

Amy-Lee Bredlau's contributions to the field of oncology through innovative therapeutic strategies exemplify the vital role of inventors in advancing healthcare solutions. With his patent on combination therapy for brain cancer, Bredlau is poised to influence treatment paradigms and improve patient outcomes, reflecting the promise of continued innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…